跳至主要内容
临床试验/NCT00814099
NCT00814099
已完成
不适用

Sedation Management in Pediatric Patients With Acute Respiratory Failure

University of Pennsylvania62 个研究点 分布在 1 个国家目标入组 2,449 人2009年1月1日

概览

阶段
不适用
干预措施
Usual approach to sedation management
疾病 / 适应症
Respiratory Insufficiency
发起方
University of Pennsylvania
入组人数
2449
试验地点
62
主要终点
Duration of mechanical ventilation
状态
已完成
最后更新
昨天

概览

简要总结

People with acute respiratory failure usually require the use of an artificial breathing machine, known as a mechanical ventilator. Sedative medications, which help keep people calm and reduce anxiety, are often prescribed for children who are on mechanical ventilators. However, the longer that sedative medications are used, the longer a child may need to remain on mechanical ventilation. This study will evaluate the effectiveness of a team approach to sedation management that aims to reduce the number of days that children with acute respiratory failure require mechanical ventilation.

详细描述

People who are hospitalized for acute respiratory failure are typically supported on mechanical ventilation, which delivers oxygen and a continuous level of pressure to the damaged lungs. Over 90% of infants and children supported on mechanical ventilation receive some form of sedation medication, which helps keep them safe, calm, and comfortable. Unfortunately, the use of sedation medications may prolong the duration of mechanical ventilation, which can lead to an increased risk for pneumonia and other complications. Recent studies among adults in intensive care units (ICUs) have shown that when doctors and nurses work together as a team to manage the use of sedation medication, patients are taken off mechanical ventilation sooner and with fewer side effects. This team strategy includes the following: * Training and discussion between doctors and nurses regarding which sedative medications should be used * Having doctors and nurses jointly identify the patient's progress and a daily sedation medication goal for the patient * Having nurses use a decision-making tool to help guide changes in a patient's sedative medication dose * Keeping track of patient care, which allows doctors and nurses to evaluate the effectiveness of how they manage each patient's sedative medication use This study will examine the use of the sedation management strategy for infants and children in pediatric ICUs who have acute respiratory failure and require mechanical ventilation. The purpose of the study is to evaluate whether this team approach to sedation medication management is more effective than the usual approach at reducing the amount of time children remain on mechanical ventilators. Study researchers will also examine the cost-effectiveness of this approach and associated quality of life factors. All participants will be enrolled within 24 hours of starting mechanical ventilation and will be monitored until they receive their last dose of sedative medication, hospital discharge, or Day 28 (whichever comes first). During a 3-month baseline period, all participating pediatric ICUs will provide their usual sedation management, and study researchers will review participants' medical records on a daily basis. Each pediatric ICU will then be randomly assigned to either the control group or the team approach group. Pediatric ICUs in the control group will continue to provide usual care for sedation management. Pediatric ICUs in the team approach group will implement the team approach sedation management guidelines. For both groups, pain and sedation levels will be monitored daily, and study researchers will review participants' medical records on a daily basis, too. Six months after hospital discharge, half of the participants and their parents will complete a follow-up survey and take part in a telephone interview to assess quality of life, psychological factors, and health-related resource use.

注册库
clinicaltrials.gov
开始日期
2009年1月1日
结束日期
2013年12月1日
最后更新
昨天
研究类型
Interventional
研究设计
Parallel
性别
All

研究者

责任方
Sponsor

入排标准

入选标准

  • At least 2 weeks of age (and at least 42 weeks post-menstrual age) and less than 18 years of age
  • Intubated and mechanically ventilated for acute lung disease

排除标准

  • Cyanotic heart disease with unrepaired or palliated right to left intracardiac shunt
  • History of single ventricle at any stage of repair
  • Congenital diaphragmatic hernia or paralysis
  • Primary pulmonary hypertension
  • Critical airway or anatomical obstruction of the lower airway
  • Ventilator dependent upon pediatric ICU admission
  • Neuromuscular respiratory failure
  • Spinal cord injury above the lumbar region
  • Pain managed by patient-controlled analgesia or epidural catheter
  • Patient transferred from an outside ICU where sedatives had already been administered for more than 24 hours

研究组 & 干预措施

1

Participants will receive care at a pediatric ICU that is continuing the usual approach to sedation management.

干预措施: Usual approach to sedation management

2

Participants will receive care at a pediatric ICU that is implementing the team approach to sedation management.

干预措施: Team approach to sedation management

结局指标

主要结局

Duration of mechanical ventilation

时间窗: Measured from the time of endotracheal intubation to the end of scheduled sedation therapy, hospital discharge, or Day 28 (whichever comes first)

次要结局

  • Time to recovery of acute respiratory failure(Measured from the time of endotracheal intubation to when participants first meet the criteria to be tested for extubation readiness)
  • Duration of weaning from mechanical ventilation(Measured from the time participants meet the criteria to be tested for extubation readiness until the time of the first successful extubation (defined as extubation for more than 24 hours))
  • Occurrence of adverse events(Measured for the duration of the study)
  • Detection of life-threatening neurological events(Measured for the duration of the study)
  • Total sedative exposure(Measured for the duration of the study)
  • Occurrence of iatrogenic withdrawal symptoms(Measured for the duration of the study)
  • Pediatric ICU and hospital length of stay(Measured for the duration of the study)
  • Hospital costs(Measured for the duration of the study)
  • Study implementation costs and cost-effectiveness(Measured for the duration of the study)
  • In-hospital mortality(Measured for the duration of the study)
  • Post-discharge quality of life and emotional health(Measured 6 months after pediatric ICU discharge)

研究点 (62)

Loading locations...

相似试验